Insider Stock Trading History of Hislop Colin


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hislop Colin since year 2005. The trader's CIK number is 1314902. At the time of this reporting, Hislop Colin is the Chief Medical Officer of Versartis, Inc. . (stock ticker symbol VSAR). See this page for all insider trading activities at Versartis, Inc. .

Note that in the past Hislop Colin also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Hislop Colin since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-04-04 VSAR Versartis, Inc. Option Ex 35,000 8.17 285,950
2017-04-04 VSAR Versartis, Inc. Sale 35,000 21.20 742,000
2015-11-13 ANTH Anthera Pharmaceuticals Inc Sale 12,500 5.31 66,337
2015-11-13 ANTH Anthera Pharmaceuticals Inc Option Ex 12,500 1.61 20,125
2015-11-11 ANTH Anthera Pharmaceuticals Inc Sale 5,000 5.38 26,900
2012-02-23 ANTH Anthera Pharmaceuticals Inc Option Ex 40,000 .26 10,400
2012-02-03 ANTH Anthera Pharmaceuticals Inc Sale 30,000 8.20 245,999
2011-11-08 ANTH Anthera Pharmaceuticals Inc Option Ex 15,000 .26 3,900
2011-11-08 ANTH Anthera Pharmaceuticals Inc Sale 15,000 6.74 101,160
2011-07-12 ANTH Anthera Pharmaceuticals Inc Option Ex 15,000 .26 3,900
2011-06-29 ANTH Anthera Pharmaceuticals Inc Option Ex 10,000 .26 2,600
2010-09-21 ANTH Anthera Pharmaceuticals Inc Option Ex 14,683 .26 3,817
2010-08-18 ANTH Anthera Pharmaceuticals Inc Buy 500 4.80 2,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hislop Colin (Chief Medical Officer of Versartis, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.